BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rouzé A, Jaffal K, Nseir S. How could we reduce antifungal use in the intensive care unit? World J Clin Infect Dis 2015; 5(4): 55-58 [DOI: 10.5495/wjcid.v5.i4.55]
URL: https://www.wjgnet.com/2220-3176/full/v5/i4/55.htm
Number Citing Articles
1
Karim Jaffal, Julien Poissy, Anahita Rouze, Sébastien Preau, Boualem Sendid, Marjorie Cornu, Saad Nseir. De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safetyAnnals of Intensive Care 2018; 8(1) doi: 10.1186/s13613-018-0392-8
2
Jaffal Karim, Bayon Constance, Kreitmann Louis, Rouzé Anahita, Labruyere Marie, Stoclin Annabelle, Reignier Jean, Brunin Guillaume, Dartevel Anais, Sendid Boualem, Labreuche Julien, Nseir Saad. Early de-escalation of antifungal treatment in critically ill immunocompromised patients with proven or probable invasive candidiasis: a retrospective multicentre studyAnnals of Intensive Care 2026;  doi: 10.1016/j.aicoj.2026.100139